Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Proteomic Characterization of An Isogenic Multiple Myeloma Cell Line Model of Bortezomib Resistance

*Catriona A. Hayes, MD, *Paul Dowling, PhD, Joseph Negri, Michael Henry, Leutz Buon, Jana Jakubikova, PhD, Jake E Delmore, Douglas W. McMillin, PhD, Steffen Klippel, PhD, Hannah M. Jacobs, Niels W.C.J. van de Donk, MD, PhD, Eugen Dhimolea, PhD, Panisinee Lawasut, MD, MSc, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Martin Clynes, PhD, *Peter O Gorman, MD, PhD, *Constantine S. Mitsiades, MD, PhD

Blood (2011) 118 (21): 1820.

https://doi.org/10.1182/blood.V118.21.1820.1820

Published: 2011

Journal Articles

Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing

Niels W.C.J. van de Donk, MD, PhD, Henk M. Lokhorst, MD, Maarten Emmelot, Tineke Aarts-Riemens, Douglas W. McMillin, PhD, Gullu Gorgun, PhD, Steffen Klippel, PhD, Eugen Dhimolea, PhD, Jana Jakubikova, PhD, Catriona A. Hayes, MD, Panisinee Lawasut, MD, Jake E Delmore, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD, Tuna Mutis, MD PhD

Blood (2011) 118 (21): 1838.

https://doi.org/10.1182/blood.V118.21.1838.1838

Published: 2011

Journal Articles

Development of New Treatment Strategies Targeting Clonogenic and Tumorigenic Myeloma Side Population.

Jana Jakubikova, PhD, Steffen Klippel, PhD, Efstathios Kastritis, MD, John Daley, Melissa Ooi, MD, Jake Delmore, Jacob P. Laubach, MD, Paul G Richardson, MD, Jan Sedlak, PhD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD

Blood (2010) 116 (21): 1581.

https://doi.org/10.1182/blood.V116.21.1581.1581

Published: 2010

Journal Articles

Synergistic Enhancement of Conventional Anti-MM Drugs Efficacy with Plant Isothiocyanates: Therapeutic Implications

Jana Jakubikova, PhD, Melissa Ooi, MD, Steffen Klippel, PhD, Jake Delmore, Jacob P. Laubach, MD, Paul G Richardson, MD, Jan Sedlak, PhD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD

Blood (2010) 116 (21): 5016.

https://doi.org/10.1182/blood.V116.21.5016.5016

Published: 2010

Journal Articles

Essential Role of Jun Family Transcription Factors in PU.1-Induced Leukemic Stem Cell Transformation.

Ulrich Steidl, MD, PhD, Frank Rosenbauer, PhD, Roel G.W Verhaak, Xuesong Gu, PhD, Hasan H. Otu, PhD, Shakir Kolia, PhD, Bronwyn M. Owens, PhD, Steffen Klippel, PhD, Katharina Wagner, MD, Manuel Aivado, MD, Emmanuelle Passegue, PhD, Towia A. Libermann, PhD, Ruud Delwel, PhD, Daniel G. Tenen, MD

Blood (2005) 106 (11): 463.

https://doi.org/10.1182/blood.V106.11.463.463

Published: 2005

Journal Articles

Knockdown of the Transcription Factor PU.1 Causes Characteristic Transcriptional Changes in Hematopoietic Stem Cells Prior to Leukemic Transformation.

Ulrich Steidl, MD PhD, Frank Rosenbauer, PhD, Xuesong Gu, PhD, Bronwyn Owens, PhD, Steffen Klippel, PhD, Katharina Wagner, MD, Manuel Aivado, MD, Towia A. Libermann, PhD, Daniel G. Tenen, MD

Blood (2004) 104 (11): 1112.

https://doi.org/10.1182/blood.V104.11.1112.1112

Published: 2004

NARROW

Proteomic Characterization of An Isogenic Multiple Myeloma Cell Line Model of Bortezomib Resistance

Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing

Development of New Treatment Strategies Targeting Clonogenic and Tumorigenic Myeloma Side Population.

Synergistic Enhancement of Conventional Anti-MM Drugs Efficacy with Plant Isothiocyanates: Therapeutic Implications

Essential Role of Jun Family Transcription Factors in PU.1-Induced Leukemic Stem Cell Transformation.

Knockdown of the Transcription Factor PU.1 Causes Characteristic Transcriptional Changes in Hematopoietic Stem Cells Prior to Leukemic Transformation.

Email alerts

ASH Publications

American Society of Hematology

Proteomic Characterization of An Isogenic Multiple Myeloma Cell Line Model of Bortezomib Resistance

Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing

Development of New Treatment Strategies Targeting Clonogenic and Tumorigenic Myeloma Side Population.

Synergistic Enhancement of Conventional Anti-MM Drugs Efficacy with Plant Isothiocyanates: Therapeutic Implications

Essential Role of Jun Family Transcription Factors in PU.1-Induced Leukemic Stem Cell Transformation.

Knockdown of the Transcription Factor PU.1 Causes Characteristic Transcriptional Changes in Hematopoietic Stem Cells Prior to Leukemic Transformation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only